Surmount Laboratories Limited - Due diligence report

A 360° intelligence report on Surmountlab: trust score, financial health, credit view, compliance, directors, growth and distress signals - …

1996-03-28 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
SL Surmount Laboratories Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Surmountlab — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Surmountlab is assessed as Low Risk with a Trust Score of 78/100. Surmountlab is an active public limited indian non-government company incorporated in 1996, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Surmount Laboratories Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
56/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 3 open (24.00 cr) · 4 satisfied (24.80 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others4 48.0 cr
Punjab National Bank2 48.0 cr
Dena Bank1 48.0 cr
Compliance Score: 56/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 2 court forum(s).
  • 3 auditor resignation(s) filed - latest: P V Jain & Co. LLP on 2022-07-15.
  • Delayed payments to MSME suppliers disclosed (52 disclosure(s)).
  • 2 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
MINESH DHIRENDRA MEHTA 01234567 Director 01/04/2018 6 yrs Approved
DHIRENDRA MAGANLAL MEHTA 01234567 Director 01/04/2018 6 yrs Approved
KAVIT DHIRENDRAKUMAR MEHTA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
Operating for 30+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Compliance score is weak (56/100).
3 open charge(s) registered - assets are encumbered.
3 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 4.45 cr.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence68/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment76/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 24.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view83/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
01 Mar 2025
Charge satisfied
Others
30 Sep 2024
Last AGM held
Annual general meeting
29 Sep 2024
Director ceased
MINESH DHIRENDRA MEHTA
31 Mar 2024
Latest balance sheet
Filed with ROC
15 Dec 2023
Charge created
Others - 50.00 Lakh
15 Nov 2022
Charge created
Others - 15.00 cr
04 Oct 2022
Charge created
Others - 6.00 cr
30 Sep 2022
Director ceased
KAVIT DHIRENDRAKUMAR MEHTA
31 Aug 2022
Director appointed
KAVIT DHIRENDRAKUMAR MEHTA (Director)
31 Dec 2020
Director ceased
DHIRENDRA MAGANLAL MEHTA
27 Aug 2020
Director appointed
DHIRENDRA MAGANLAL MEHTA (Director)
27 Mar 2018
Securities allotted
200000 Equity Shares - 30.00 Lakh raised
04 Dec 2017
Director appointed
MINESH DHIRENDRA MEHTA (Director)
31 Mar 2017
Securities allotted
160000 Equity Shares - 24.00 Lakh raised
13 May 2016
Charge satisfied
Punjab National Bank
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Centurion Healthcare Private Limited U24232GJ2012PTC072346 Vadodara, Gujarat, India
Intermed Laboratories Private Limited U24230MH2019PTC331617 Lower Parel, Maharashtra, India
Bioaltus Pharmaceuticals Private Limited U74900MH2014PTC254786 Thane West, Maharashtra, India
Impulse Pharma Private Limited U24230MH2002PTC137705 Thane, Maharashtra, India
Mcw Healthcare U85110MP2000PTC014128 M.P., Madhya Pradesh, India
Baroque Pharmaceuticals U24230GJ1993PTC020695 Ahmedabad, Gujarat, India
Imerys Vizag Private Limited U26933AP2011PTC118564 Anakapalle, Andhra Pradesh, India
Shivalik Remedies Private Limited U24232DL2005PTC133923 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Surmountlab before audits and certifications: compliance score 56/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Surmountlab: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Surmountlab - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Surmountlab pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Surmountlab - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Surmountlab an active company?

Surmountlab has MCA status “Active” with a compliance score of 56/100 (Moderate).

Is Surmountlab financially healthy?

Surmountlab has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Surmountlab?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Surmountlab?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Surmountlab have loans or charges against its assets?

3 open charge(s) are registered against its assets, and 4 earlier charge(s) stand satisfied.

Is Surmountlab up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 56/100 (Moderate).

Is it risky to lend to Surmountlab?

Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.